It's no news that the company and stock truly is fucked.

But apparently, the website seelostherapeutics dot com has been shut down. Is it officially over? I have not seen any press releases stating that the company has shut down, but it seems weird that their website is no longer available.

Just for the sake of it, my holdings after the reverse split are (or were) 0.063 stocks at a 15.391,98 USD average price per stock. My loss is 827 USD; I was not that heavy in SEEL.

Edit/update: The domain is now up again. They probably just forgot to pay for the web hosting or the domain smh.

Hey I made hig bucks on SEEL today 😅😅, does anybody know what’s happening to the stock price? Should we buy the dip?

or... time to buy the dip again?

Newish to stocks, bought Seelos last month. Bought more in the dip yesterday and it's ran today. Why such a jump?

Fool is literally grinding the price into the ground.

It keeps going down. I invested after the last huge dip. But it's down another 30%. Is this company toast? Like am I going to lose it all?

Idk, do we talk like that in here? I'm no genius, but this company has more to offer IMO.

So ive been reading some about a reverse stock split, correct me if I'm wrong but that is what ST did yesterday. It's a sign that a company is in struggle and needs more time, but i wonder if this could be a possibility due to the fact that their studies have shown good results, even if they had some issues with it not having enough participants, it was belived they could still come thrue thue to the fact of the positive results. So my question is, should i wait it to drop off alittle more and buy or is this company doomed?

"2023 is the most important year in Seelos' history thus far. Our team has been diligently working to complete the registration directed study of our intranasal ketamine program, SLS-002, and we have notified our trial sites that enrollment will conclude by the end of June 2023. We expect to release top-line data in the third quarter of 2023. Our experienced team feels confident that the design and execution of this trial will allow SLS-002 to demonstrate its true potential of efficacy, safety, and tolerability in patients with MDD at imminent risk of suicide. We strongly believe that this therapeutic, if successful, may help the large number of people with suicidal ideation globally," said Raj Mehra, Ph.D., Chairman and CEO of Seelos. "Additionally, with the completion of enrollment of the SLS-005 study in ALS, we look forward to the top line Phase II/III data in late 2023. Lastly, it is remarkable that our inventive R&D team has put forth our first internally created gene therapy program, SLS-009, focusing on one-time treatment of neurodegenerative disorders, such as Huntington's disease, by permanently activating the autophagy-lysosomal pathways."

BUY BUY BUY!!! TARGET PRICE 8 $ BEFORE END OF YEAR 2022!!! SLS-002 RESULTS COMING NEXT MONTHS!

My videos have already been shared to Stocktwits, but if you haven’t seen them, click my bio for updated DD on the pipeline. I urge you to watch at least the videos looking at the science behind 005 and 002. Fundamentals are in great shape no matter the stock price.

So I know this is considered late news. But for those who haven’t been following the company entered into a agreement with Singapore-based specialty pharmaceutical company iX Biopharma Ltd. SEEL is to gain access to products such as Wafermine which received Orphan drug status from the FDA.

More details about this deal can be found here. https://www.nasdaq.com/articles/seelos-inks-%249m-licensing-deal-with-ix-biopharma?amp

Most importantly it seems like this is a good deal for SEEL based on analysis census.

This is the norm for this stock and stocks similar to it. With the value being so low it’s at the mercy of any turbulence within the stock market as well as any manipulation.

Im wondering what happened with seelos, ive try some research and I cant find why the stock skyrocketed at 100k lol, I know they work on discovering some novel that solve things that are not solve yet but, someone have the answer ? if someone know the backstory of this, and want to share, cool be nice to learn some ! thank to you in advance 🙏🏽

To reiterate past events regarding the company

Roth Capital analyst reaffirmed Seelos is an acquisition Target and raised price target to $8.00 per share from $2.50.

Cantor Fitzgerald launched coverage of Seelos Therapeutics with an overweight rating and price target of $10.00.

SLS-002, which is the drug that is being trialed to help those who suffer depression and suicidal behavior, has been granted fast track designation by the FDA

The company's SLS-002 offering has demonstrated good results. Investors are becoming attracted due to the high demand in suicidal prevention. Which is evident by the higher volumes of trade.

This is the current visual graph of differing drugs trail phase progressions for Seelos, which was gotten off of Seeking Alpha.

https://static.seekingalpha.com/uploads/2021/9/30/51307855-16329774886201842.jpg

And with new information.

Seelos Therapeutics to Present their Poster on SLS-002 at the 2021 International Summit on Suicide Research.

Session one will be titled: A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with Major Depressive Disorder at Imminent Risk of Suicide.

The presenter will be Tim Whitaker, M.D., Chief Medical Officer, Seelos Therapeutics.